Rituxan articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2015/03/24 11:17
2015/03/24 11:17
5d
Novel Drug and Biosimilar Launches to Transform Rheumatoid Arthritis Treatment Market Dynamics by 2023 This report provides annualized Rheumatoid Arthritis (RA) market revenue, annual cost of therapy...
2015/03/24 11:17
2015/03/24 11:17
Latest videos
2015/03/23 14:10
2015/03/23 14:10
5d
NEW YORK — Biogen Idec Inc. is shortening its name to just Biogen as of Monday. The biotechnology company is also introducing a new corporate logo. But it will maintain "BIIB" as its ticker...
2015/03/19 00:17
2015/03/19 00:17
10d
The drivers of growth in this market include the increasing RA patient population, along with economic growth and government initiatives to increase access to healthcare. However, Chinese physicians'...
2015/03/06 21:28
2015/03/06 21:28
22d
The approval is significant because it opens the door to a new class of potentially cheaper lifesaving drugs for millions of Americans. It concerns a class of drugs known as biologics, which are made...
2015/03/03 05:48
2015/03/03 05:48
26d
Amgen's investors are focusing a lot of attention on the potential multibillion-dollar market for its cholesterol-busting drug evolocumab; however, it's Amgen's research into biosimilars that could...
2015/03/02 23:48
2015/03/02 23:48
26d
When Gilead Sciences takes aim at a disease, investors ought to pay attention. The biotech giant's remarkable track record of developing and commercializing blockbuster therapies has turned it into...
2015/03/24 11:17
2015/03/24 11:17
Latest from Twitter